Home Am I at Risk? Obesity, Overweight & PAD Risk

Obesity, Overweight & PAD Risk

What are overweight and obesity?

Overweight and obesity are conditions in which a person is carrying too much extra body fat. The two terms do not mean exactly the same thing: obesity is a more severe form of being overweight.

Women who are overweight or obese are more likely to develop conditions that put them at risk for peripheral artery disease (PAD), including high blood pressure, diabetes, high cholesterol and a high C-reactive protein level. Excess body fat also puts you at risk for many other heart and blood vessel problems, including coronary artery disease, stroke, heart failure, and blood clots in the veins. On average, a woman who is overweight will die 3 years earlier than if she had a healthy weight, and an obese woman will die more than 7 years earlier.1

More than two-thirds of American women are overweight or obese.2 The burden of excess weight affects certain races more than others: obesity is most common in African American women, followed by Hispanic and white women, with a lower rate in Asians.3 It is also a growing problem among children.4

See also:

Overweight, Obesity & Vein Disease Risk
Overweight, Obesity & Heart Risk
Overweight, Obesity & Stroke Risk
Overweight, Obesity & Heart Failure

What causes overweight and obesity?

The main causes of being overweight or obese are eating too many calories and not being physically active enough. If you eat more calories than your body burns up, the extra calories are stored as fat. Other factors that may affect your weight include your genes (obesity tends to run in families),5,6 your metabolism (how your body processes food),7 and your age (your metabolism slows down as you get older). Sometimes an illness or medications (such as those used to treat mood disorders, seizures, migraines, high blood pressure, and diabetes) can contribute to weight gain. However, calories in (from food and drink) and calories out (burned during exercise) remain the keys to weight control.

How is obesity measured?

Because your ideal weight is related to how tall you are, the most commonly used way to evaluate your body weight and determine your ideal weight is called the Body Mass Index, or BMI. Your BMI is calculated by taking your weight in kilograms and dividing it by your height in meters squared. A woman with a BMI between 25 and 29 is considered overweight, and a woman with a BMI of 30 or more is considered obese.9

Click here to calculate your BMI.

BMI Categories8
Category BMI
Underweight Less than 18.5
Normal 18.5 to 24.9
Overweight 25 to 29.9
Obese 30 or higher

Although the BMI is the most widely used tool to measure the health effects of weight, it does have limitations. For some people, the BMI may not be an accurate gauge of health risk. For example, BMI can overestimate body fat in women who have an athletic, muscular build, and underestimate body fat in women who have lost muscle mass or in older women. Some races also have different natural amounts of body fat, and BMI may not be as accurate in Asians, Arabs, and mixed-race Africans.

Does where I carry my weight make a difference?

In terms of your health, where you carry extra fat may be just as important as how much excess weight you have. People with excess fat in their belly area, or abdominal adiposity (so-called "apple" shape), may have more health risks than people who carry their weight in their hips and thighs ("pear" shape).

Many different tools have been developed to attempt to measure where a woman carries her body fat and predict her risk of health problems caused by extra fat. The most common of these are waist circumference and waist-to-hip ratio.

Your waist circumference is the distance around your waist, measured at the level of your belly button.9 A waistline greater than 35 inches for women and 40 inches for men increases the risk for having obesity-related risk factors and heart and blood vessel problems. However, these cutoffs may be too high for very short people (less than 5 feet tall) and people from Asia and East India.9,10

Waist Circumference
Women Men
High Risk More than 35 inches (88 cm) More than 40 inches (102 cm)
Waist-to-Hip Ratio = Waist ÷ Hip
Desirable 0.80 or less for women
At-risk 1.0 or more

Your waist-to-hip ratio is the distance around your waist divided by the distance around your hips. An ideal waist-to-hip ratio for women is 0.80 or less; a waist-to-hip ratio of 1.0 or more increases your risk for heart and blood vessel disease.

Another relatively new measure is the waist-to-thigh ratio, or WTR. This works in a similar way to the waist-to-hip ratio, but thigh circumference may be easier to measure accurately. There are not yet established levels for a desirable waist-to-thigh ratio.

Does obesity increase my risk of PAD?

Four out of five people with PAD are overweight or obese.11 In the Framingham Heart Study (3,313 patients, 53% were women), each 5-point increase in BMI (equivalent to a change from being slightly overweight to being obese) made a person 40% more likely to develop PAD.12

However, in this and other studies, researchers have found that obesity itself does not raise your risk of PAD.13,14 Instead, obese women are more likely to develop PAD than their healthy-weight counterparts because excess body fat causes many other conditions that raise a woman’s PAD risk. These include:

  • High blood pressure: Obese women are nearly 3 times as likely to have high blood pressure than those who are at a healthy weight. Overweight women are nearly twice as likely.15
  • Diabetes: Overweight women are more than twice as likely to develop type 2 diabetes as people who are not overweight.
  • High cholesterol: Excess fat raises your LDL (bad) cholesterol and lowers your HDL (good) cholesterol. Low HDL cholesterol has been strongly linked to the risk of PAD in women.

Some studies have found that measuring abdominal fat, rather than overall BMI, can better predict a woman’s risk of developing PAD. In one study of 5,057 patients (half were women), women with a very large waist circumference (more than 40 inches) were more than 3 times as likely to develop PAD as those with small waists, even after other PAD risk factors were taken into account.16 In addition, the larger a woman’s waist-to-thigh ratio, the higher her risk of developing PAD.

Will losing weight reduce my risk of PAD?

All women should achieve and maintain a healthy weight (a BMI between 18.5 and 24.9) to prevent heart and blood vessel disease. Losing weight lowers your overall PAD risk through its beneficial effects on many PAD risk factors. Even losing as little as 10% of your body weight can:8,15,17

  • Lower your blood pressure
  • Reduce your risk of developing diabetes, and help control your blood sugar if you already have diabetes
  • Raise your HDL ("good") cholesterol level and lower your levels of total cholesterol and LDL ("bad") cholesterol

How can I lose weight?

To learn about your options for losing weight and reducing the associated PAD risks, see our Weight Loss Guide.

In addition to helping you lose weight, regular exercise can relieve symptoms and increase independence in women with PAD. See Exercise and Lower Extremity PAD Rehabilitation (coming soon) to learn more.

What about weight gain during pregnancy?

When a woman is pregnant, it is normal for her to gain weight. If you have concerns about your weight, you should discuss them with your doctor; pregnant women should never try to lose weight. The recommended weight gain during pregnancy depends on your weight before you became pregnant. As a rough guide, women who are of normal weight should gain 25 to 35 pounds during pregnancy. Overweight women should only gain 15 to 25 pounds, and obese women should gain no more than 15 pounds.18

See also: Pregnancy & Vein Disease Risk

For More Information

NHLBI Obesity Education Initiative
Centers for Disease Control and Prevention - Obesity and Overweight
American College of Sports Medicine – Physical Activity & Public Health Guidelines


  1. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. Jan 7 2003;138(1):24-32.
  2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. Jan 20;303(3):235-241.
  3. Seo DC, Torabi MR. Racial/ethnic differences in body mass index, morbidity and attitudes toward obesity among U.S. adults. J Natl Med Assoc. Aug 2006;98(8):1300-1308.
  4. Reilly JJ. Descriptive epidemiology and health consequences of childhood obesity. Best Pract Res Clin Endocrinol Metab. Sep 2005;19(3):327-341.
  5. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. Mar 2005;6(3):221-234.
  6. Mora S, Yanek L, Moy TF, Fallin D, Becker LC, Becker DM. Interaction of body mass index and Framingham Risk Score in predicting incident coronary disease in families. Circulation. 2005;111:1871-1876.
  7. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr. 2005;25:391-406.
  8. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. National Heart, Lung, and Blood Institute in cooperation with the National Institute of Diabetes and Digestive and Kidney Diseases U.S. Department of Health and Human Services; September 1998. No. 98-4083.
  9. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. Sep 1998;6 Suppl 2:51S-209S.
  10. Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. Nov 5 2005;366(9497):1640-1649.
  11. Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. Jan 11 2006;295(2):180-189.
  12. Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. Jun 2002;143(6):961-965.
  13. Ostchega Y Fau - Paulose-Ram R, Paulose-Ram R Fau - Dillon CF, Dillon Cf Fau - Gu Q, Gu Q Fau - Hughes JP, Hughes JP. Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999-2004. (0002-8614 (Print)).
  14. Lane Js Fau - Vittinghoff E, Vittinghoff E Fau - Lane KT, Lane Kt Fau - Hiramoto JS, Hiramoto Js Fau - Messina LM, Messina LM. Risk factors for premature peripheral vascular disease: results for the National Health and Nutritional Survey, 1999-2002.
  15. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. Sep 9 2002;162(16):1867-1872.
  16. Bing L, Jing Z, Molly EW, Donna RP, Charles BE. Abdominal obesity and peripheral vascular disease in men and women: A comparison of waist-to-thigh ratio and waist circumference as measures of abdominal obesity. Atherosclerosis.208(1):253-257.
  17. Janssen I, Katzmarzyk PT, Ross R. Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch Intern Med. Oct 14 2002;162(18):2074-2079.
  18. Mosca L, Grundy SM, Judelson D, et al. Guide to Preventive Cardiology for Women.AHA/ACC Scientific Statement Consensus panel statement. Circulation. May 11 1999;99(18):2480-2484.

Filed in Am I at Risk? > Peripheral Artery Disease